MedTrace Logo

The Personalized Chinese Herb Formulas Over Hypertensive Bradyarrhythmia

NCT04505228 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2020-08-10

No results posted yet for this study

Summary

72 patients who have been diagnosed with hypertensive bradyarrhythmia were selected and randomly divided into research group and control group. The research group received regular medication against hypertension and the personalized formulas based on syndrome differentiation, meanwhile the control group only received the regular medication. The five symptoms (palpitation, short of breath, angina, dizzy and lumbar debility) were graded and used for evaluation of treatment.

Conditions

  • Hypertensive Heart Disease

Interventions

DRUG

Safflower (Carthamus Tinctorius) IgG4 | Serum | Allergy

The designed Chinese herb formulas

DRUG

Atropine Sulfate

The basic treatment for heart disease

Sponsors & Collaborators

  • Qingdao Fifth People's Hospital

    collaborator UNKNOWN

  • Jun Xiao

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-20
Primary Completion
2020-03-20
Completion
2020-06-20

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04505228 on ClinicalTrials.gov